Canadian cannabis company Organigram enters fight for Aurora

Organigram's potential involvement in the takeover fight for Aurora is noteworthy, particularly given British American Tobacco's (BAT) 19% stake in Organigram. This development could have significant implications for the Canadian cannabis industry, where consolidation and strategic partnerships have been on the rise.

The fact that Curaleaf's bid for Aurora expires on December 4 adds a sense of urgency to the situation. If Organigram were to make a competing offer, it could potentially alter the dynamics of the takeover fight and create new opportunities or challenges for the companies involved. As a hemp-focused publication, it's worth noting that while this news is more directly relevant to the cannabis industry, it could have indirect implications for hemp and CBD businesses operating in Canada or partnering with Canadian companies.

Industry stakeholders should watch how this situation unfolds, particularly in terms of whether Organigram will make a formal bid for Aurora and how BAT's stake in Organigram influences the company's decision-making. Additionally, the outcome of this takeover fight could have broader implications for the Canadian cannabis industry, including potential impacts on market competition and the strategic positioning of various players.

Originally reported by mjbizdaily.com. HempNews adds analysis for cannabis & hemp readers.